Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

See How to

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      

Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2021)

GECT2021

Categories

Date of beginning

Saturday, 29 May 2021

Duration

3 days

Deadline for abstracts

Thursday, 29 April 2021

City

Guilin

Country

China

Contact

Ms Zhang

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2021) Conference Date: May 29-31, 2021 Conference Venue: Guilin, China Website: https://www.maymeeting.org/conference/GECT2021/ Online Registration: https://www.maymeeting.org/RegistrationSubmission/default.aspx?ConferenceID=1353 Email Registration: This email address is being protected from spambots. You need JavaScript enabled to view it. Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2021) will be held from May 29-31, 2021 in Guilin, China. GECT 2021 will cover issues on Biomedicine, Clinical Application of Gene Editing, CRISPR Systems and CRISPR Technologies, Effective Delivery for Genes in Vitro, Gene Knock In and Genomic Screening, Genome Engineering and DNA repair, Single Base Editing, etc. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods. If you wish to serve the conference as an invited speaker, please send email to us with your CV. We'll contact with you asap. Publication and Presentation Publication: All the accepted papers will be published by a peer-reviewed open access journal that can ensure the widest dissemination of your published work, for more information, please contact us (This email address is being protected from spambots. You need JavaScript enabled to view it.) Index: CNKI and Google Scholar Note: If you want to present your research results but do NOT wish to publish a paper, you may simply submit an Abstract to our Registration System. Contact Us Email: This email address is being protected from spambots. You need JavaScript enabled to view it. (This email address is being protected from spambots. You need JavaScript enabled to view it.) Tel: +86 13264702250 QQ: 1349406763  WeChat: 3025797047 Twitter: conf_Committee Attendance Methods Submit full paper (Regular Attendance+Paper Publication+Presentation) You are welcome to submit full paper, all the accepted papers will be published by Open access journal. 2. Submit abstract (Regular Attendance+Abstract+Presentation) 3. Regular Attendance (No Submission Required) Conference Topics Biomedicine Cas Genes and CRISPR Subtypes Clinical Application of Gene Editing CRISPR Biology CRISPR Systems and CRISPR Technologies CRISPR-Associated Systems Delivery and specificity of CRISPR-based tools Different Gene Delivery Systems Disease Models Effective Delivery for Genes in Vitro Gene Drive Gene Editing Technology and Gene Editing Efficiency Gene Editing-Based Safety and Ethics Gene Function Gene Knock In and Genomic Screening Gene Therapy Genetic Vaccines Genetics and Genomic Medicine Genome Editing and Genome Regulation Genome Engineering and DNA repair In Situ Gene Editing In Vitro Genetic Depletion In Vivo Gene Editing Locus Structure Molecular Epigenetics Nano-Therapy                          Off-Target Effects Optimizing Repair of CRISPR-Generated DNA Breaks Programmable Gene Expression Regulatory, Safety Aspects of Cell and Gene Therapy Repeated Sequences RNA Editing Technology RNA Guided Nuclease for Genome Modifications RNAi and Gene Therapy RNAi based Screening Technologies Single Base Editing Spacer Acquisition, Biogenesis, and Interference Targeted Gene Replacement Vectors for Gene Therapy Viral Gene Therapy